LP20808-9

Vigabatrin

Active

Description

Vigabatrin is an antiepileptic drug that inhibits the catabolism of gamma-aminobutyric acid (GABA) by irreversibly inhibiting GABA transaminase. It is an analog of GABA, but it is not a receptor agonist. Vigabatrin is also used to treat seizures in succinic acid semialdehyde deficiency, which is an inborn neurotransmitter (gamma amino butyric acid) catabolism defect that causes mental retardation, hypotonia, seizures, speech disturbance, and ataxia through the accumulation of 4-hydroxybutyric acid. Vigabatrin is sold under the brand name Sabril. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Vigabatrin

Basic Part Properties

Part Display Name

Vigabatrin

Part Type

Component (Describes the core component or analyte measured)

Created On

2000-07-11

Construct for LOINC Short Name

Vigabatrin

Related Codes

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.

CodeSystem lookup

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP20808-9

ConceptMap translate

https://fhir.loinc.org/ConceptMap/$translate?system=http://loinc.org&code=LP20808-9

Language Variants Get Info

LOINC Copyright

Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.